247 related articles for article (PubMed ID: 31639291)
1. CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.
Wang LL; Zong ZH; Liu Y; Guan X; Chen S; Zhao Y
J Cell Mol Med; 2019 Dec; 23(12):8472-8481. PubMed ID: 31639291
[TBL] [Abstract][Full Text] [Related]
2. circEPSTI1 regulates ovarian cancer progression via decoying miR-942.
Xie J; Wang S; Li G; Zhao X; Jiang F; Liu J; Tan W
J Cell Mol Med; 2019 May; 23(5):3597-3602. PubMed ID: 30887698
[TBL] [Abstract][Full Text] [Related]
3. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182.
Zong ZH; Du YP; Guan X; Chen S; Zhao Y
J Exp Clin Cancer Res; 2019 Oct; 38(1):437. PubMed ID: 31666098
[TBL] [Abstract][Full Text] [Related]
4. miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.
Wu B; Zhang L; Yu Y; Lu T; Zhang Y; Zhu W; Song Q; Lv C; Guo J; Tian Y; Deng N
Cell Death Dis; 2020 May; 11(5):345. PubMed ID: 32393810
[TBL] [Abstract][Full Text] [Related]
5. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
[TBL] [Abstract][Full Text] [Related]
6. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
7. Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression.
Cao W; Zhao Y; Wang L; Huang X
Cancer Biomark; 2019; 25(1):101-113. PubMed ID: 30909190
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145.
Lin X; Yang F; Qi X; Li Q; Wang D; Yi T; Yin R; Zhao X; Zhong X; Bian C
Mol Carcinog; 2019 Dec; 58(12):2286-2296. PubMed ID: 31545000
[TBL] [Abstract][Full Text] [Related]
10. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
12. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
[TBL] [Abstract][Full Text] [Related]
13. CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis.
Du Y; Liu X; Zhang S; Chen S; Guan X; Li Q; Chen X; Zhao Y
Reprod Biol Endocrinol; 2021 Nov; 19(1):176. PubMed ID: 34847936
[TBL] [Abstract][Full Text] [Related]
14. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223.
Zhang X; Tan P; Zhuang Y; Du L
Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470
[TBL] [Abstract][Full Text] [Related]
15. The NF-κB-modulated miR-19a-3p enhances malignancy of human ovarian cancer cells through inhibition of IGFBP-3 expression.
Bai R; Cui Z; Ma Y; Wu Y; Wang N; Huang L; Yao Q; Sun J
Mol Carcinog; 2019 Dec; 58(12):2254-2265. PubMed ID: 31513316
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA-9119 suppresses in ovarian cancer cell viability via targeting the microRNA-21-5p-PTEN-Akt pathway.
Gong J; Xu X; Zhang X; Zhou Y
Aging (Albany NY); 2020 Jul; 12(14):14314-14328. PubMed ID: 32675386
[TBL] [Abstract][Full Text] [Related]
17. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
[TBL] [Abstract][Full Text] [Related]
18. CircCCT3 Acts as a Sponge of miR-613 to Promote Tumor Growth of Pancreatic Cancer Through Regulating VEGFA/VEGFR2 Signaling.
Hou JP; Men XB; Yang LY; Han EK; Han CQ; Liu LB
Balkan Med J; 2021 Jul; 38(4):229-238. PubMed ID: 34274912
[TBL] [Abstract][Full Text] [Related]
19. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
20. Silencing circular RNA UVRAG inhibits bladder cancer growth and metastasis by targeting the microRNA-223/fibroblast growth factor receptor 2 axis.
Yang C; Wu S; Wu X; Zhou X; Jin S; Jiang H
Cancer Sci; 2019 Jan; 110(1):99-106. PubMed ID: 30387298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]